U.S. market Closed. Opens in 5 hours 11 minutes

EDIT | Editas Medicine, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue78.12M19.71M25.54M90.73M20.53M31.94M13.73M6.05M1.63MN/A
Cost of Revenue6.06M6.34M5.05M158.00M96.90MN/AN/AN/AN/AN/A
Gross Profit72.06M13.38M20.49M-67.26M-76.37M31.94MN/AN/A1.63MN/A
Operating Expenses241.24M245.66M218.69M225.57M161.45M145.66M133.66M103.24M36.94MN/A
Selling, General & Admin69.65M70.70M76.18M67.58M64.56M55.01M50.50M46.26M18.09M7.65M
Research & Development171.59M174.96M142.51M158.00M96.90M90.65M83.16M56.98M18.85M5.07M
Other Operating Expenses-1.60M1.29M-1.70M16.26M-137.00K328.00KN/AN/AN/AN/A
Operating Income-169.18M-225.95M-193.15M-134.84M-140.92M-113.73M-119.93M-97.19M-35.31M-12.72M
Other Expenses / Income15.96M5.52M644.00K18.86M7.18M328.00K-391.00K5.00K-37.59M-962.00K
Before Tax Income-153.22M-220.43M-192.50M-115.98M-133.75M-109.95M-120.32M-97.18M-72.90M-13.69M
Income Tax Expenses5.90M-16.08M-7.39M-6.56M-10.28M-3.12MN/AN/AN/AN/A
Net Income-153.22M-204.35M-185.11M-109.41M-123.47M-109.95M-120.32M-97.23M-73.29M-13.99M
Interest ExpensesN/A4.22MN/AN/A-7.31M-3.44M978.00K-62.00K143.00K34.00K
Basic Shares Outstanding75.97M68.66M67.62M58.61M49.98M47.10M40.32M32.22M35.70M4.04M
Diluted Shares Outstanding75.97M68.66M67.62M58.61M49.98M47.10M40.32M32.22M35.70M4.04M
EBITDA-163.12M-225.95M-193.15M-134.84M-141.06M-113.40M-116.66M-96.09M-72.68M-13.49M
EBITDA Margin-208.80%-1,146.26%-756.13%-148.61%-687.05%-355.07%-849.82%-1,587.48%-4,461.63%0.00%
EBIT-147.32M-216.21M-192.50M-115.98M-141.06M-116.52M-119.35M-97.29M-73.15M-13.96M
EBIT Margin-188.58%-1,096.83%-753.61%-127.82%-687.05%-364.83%-869.36%-1,607.34%-4,490.55%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙